Global Active B12 Test Market to Reach USD 264.18 Million by 2031 | CAGR of 4.7%
Category : Healthcare | Published Date : Nov 2024 | Type : Press Release
Active B12 Test Market Scope & Overview:
As per the Consegic Business Intelligence newly published report, the Global Active B12 Test Market size was valued at USD 182.29 million in 2023 and is projected to register a CAGR of 4.7%, reaching USD 264.18 million by 2031. Active B12 tests measure the biologically active form of vitamin B12, holotranscobalamin, in the bloodstream, which is critical for early diagnosis of vitamin B12 deficiencies that can lead to neurological and hematological disorders.
The report comprises the Active B12 Test Market Share, Size & Industry Analysis, By Product Type (Reagents & Kits, Analyzers, Consumables), By Test Type (ELISA, RIA, CLIA, Others), By Indication (Pernicious Anemia, Folate Deficiency, Vitamin B12 Deficiency, Neurological Disorders, Others), By End-User (Hospitals, Diagnostic Laboratories, Research Institutes, Specialty Clinics, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024-2031.
The report contains detailed information on Active B12 Test Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Increasing awareness of vitamin B12 deficiencies and the growing need for accurate diagnostics drive market growth. Integration of preventive healthcare practices further supports demand for active B12 testing.
Segmental Analysis :
By Product Type:
- Reagents & Kits dominated in 2023, used widely in clinical diagnostics for their compatibility with immunoassay technologies like ELISA and CLIA.
- Analyzers are projected to grow at the highest rate, driven by automation in diagnostic labs and demand for high-throughput, accurate testing solutions.
By Test Type:
- ELISA held the largest share in 2023 due to its accuracy and cost-effectiveness, making it preferred by hospitals and diagnostic labs.
- CLIA is anticipated to grow fastest, as it supports high-sensitivity and automation, ideal for high-throughput labs.
By Indication:
- Vitamin B12 deficiency was the leading segment in 2023, driven by increased prevalence and awareness of deficiency-related health impacts.
- Neurological disorders are expected to witness rapid growth due to rising cases of neurodegenerative diseases linked to B12 deficiencies.
Based on regions, the global market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.
- North America led the market in 2023, supported by advanced healthcare infrastructure and high awareness of B12-related disorders.
- Asia-Pacific is projected to grow at the fastest rate, driven by expanding healthcare investments and improving diagnostic capabilities.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 264.18 Million |
| CAGR (2024-2031) | 4.7% |
| By Product Type | Reagents & Kits, Analyzers, Consumables |
| By Test Type | ELISA, RIA, CLIA, Others |
| By Indication | Pernicious Anemia, Folate Deficiency, Vitamin B12 Deficiency, Neurological Disorders, Others |
| By End-User | Hospitals, Diagnostic Laboratories, Research Institutes, Specialty Clinics, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, diagnostic service providers, and market leaders, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Active B12 Test Industry:
- Axis-Shield Diagnostics (UK)
- Abbott Laboratories (USA)
- Siemens Healthineers (Germany)
- Roche Diagnostics (Switzerland)
- LifeSpan BioSciences, Inc. (USA)
- Demeditec Diagnostics GmbH (Germany)
- DiaSorin S.p.A. (Italy)
Recent Industry Developments :
- April 2024: Abbott launched an advanced Active B12 Test kit, designed for improved accuracy and speed, enhancing diagnostic efficiency in clinical settings.
- February 2024: Siemens Healthineers completed a merger with a diagnostics firm to strengthen its portfolio in B12 testing solutions, expanding its market reach and product offerings.
